Insider Transactions in Q4 2025 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2025
|
Ian Michael Estepan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,187
-6.39%
|
$290,114
$22.31 P/Share
|
|
Dec 07
2025
|
Douglas S Ingram Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
539,084
+13.23%
|
-
|
|
Dec 01
2025
|
Ryan Ho Yan Wong Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-0.06%
|
$3,160
$20.96 P/Share
|
|
Nov 28
2025
|
Cristin Rothfuss EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
229
-0.16%
|
$4,809
$21.12 P/Share
|
|
Nov 17
2025
|
Louise Rodino Klapac President, R&D and Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
4,582
-2.0%
|
$82,476
$18.42 P/Share
|